Bayer's New Yaz Warning Labels Miss The Mark
For the better part of a year, we here at Greenberg and Bederman have been closely monitoring developments over the Bayer Corporation’s line of birth control pills. Yaz, Yasmin and its generic version Ocella are all immensely popular and incredibly profitable for the German drug manufacturer. Aside from simply preventing pregnancy, Bayer markets the secondary benefits of Yaz and Yasmin, which include prevention of certain types of acne, as well as relief from some of the more traumatic emotional disturbances that can come with menstruation.
What separates Yaz and Yasmin from other forms of oral contraceptive is that these pills contain a synthetic variation of the normal birth control ingredient progestin. This variation is called drospirenone, and while it can contribute to less acne and relief from emotional trauma, it also significantly raises potassium levels in the bloodstream. Elevated potassium levels can cause deep vein thrombosis, which is the formation of blood clots in the major veins and arteries in the legs. If the blood clots break apart and travel, they often get pulled into the pulmonary bloodstream, which can lead to pulmonary embolisms. Or the pieces of the blood clot can travel to the heart or brain, which can lead to heart attacks or strokes. It’s important to mention that these birth control injuries aren’t one-in-a-million occurrences. They happen with unfortunate regularity.
Continue Reading...